Cryo-cell International, Inc. (CCEL) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	2.03M
Restricted cash	0
Marketable securities and other investments	630.02K
Accounts receivable and advances (net of allowance for doubtful accounts of $1,062,040 and $783,354, respectively)	4.38M
Deferred tax assets	2.18M
Prepaid expenses and other current assets
Total current assets	10.15M
Property and Equipment-net	993.41K
Marketable securities and other investments
Investment in Saneron CCEL Therapeutics, Inc.
Deposits and other assets, net	25.5K
Deferred tax assets, less current portion	6M
Total other assets	6.4M
Total assets	17.54M
Accounts payable	1.61M
Accrued expenses	1.72M
Deferred revenue	7.09M
Total current liabilities	12.41M
Deferred revenue, net of current portion	12.07M
Long-term liability-revenue sharing agreements	1.43M
Deferred consulting obligation
Total other liabilities	22.15M
Commitments and Contingencies	0
Preferred stock ($.01 par value, 500,000 authorized and none issued)	0
Common stock ($.01 par value, 20,000,000 authorized; 11,764,325 as of August 31, 2011 and 11,752,574 as of November 30, 2010 issued and outstanding)	125.04K
Additional paid-in capital
Accumulated deficit	-27.6M
Treasury stock, at cost	-18.99M
Accumulated other comprehensive loss	55.59K
Total stockholders' deficit	-17.02M
Total liabilities and stockholders' deficit	17.54M

Entities mentioned with CCEL

View All Entities